Opaleye Management as of June 30, 2015
Portfolio Holdings for Opaleye Management
Opaleye Management holds 46 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chimerix (CMRX) | 8.1 | $20M | 440k | 46.20 | |
| Cempra | 6.7 | $17M | 490k | 34.36 | |
| Retrophin | 6.1 | $15M | 460k | 33.15 | |
| AMAG Pharmaceuticals | 5.2 | $13M | 190k | 69.06 | |
| Ariad Pharmaceuticals | 4.9 | $12M | 1.5M | 8.27 | |
| Ultragenyx Pharmaceutical (RARE) | 4.5 | $11M | 110k | 102.39 | |
| Imprimis Pharmaceuticals | 3.9 | $9.8M | 1.2M | 8.13 | |
| Supernus Pharmaceuticals (SUPN) | 3.6 | $9.1M | 535k | 16.98 | |
| Affimed Therapeutics B V | 3.2 | $8.0M | 590k | 13.47 | |
| Clovis Oncology | 3.1 | $7.9M | 90k | 87.88 | |
| Geron Corporation (GERN) | 3.1 | $7.8M | 1.8M | 4.28 | |
| Fibrogen (FGEN) | 3.0 | $7.6M | 325k | 23.50 | |
| MiMedx (MDXG) | 2.8 | $7.2M | 617k | 11.59 | |
| Neurocrine Biosciences (NBIX) | 2.8 | $6.9M | 145k | 47.76 | |
| Codexis (CDXS) | 2.7 | $6.7M | 1.7M | 3.89 | |
| Axogen (AXGN) | 2.6 | $6.7M | 2.1M | 3.14 | |
| Flamel Technologies | 2.6 | $6.6M | 310k | 21.19 | |
| Medgenics Com New | 2.6 | $6.4M | 1.1M | 6.13 | |
| Ophthotech | 2.2 | $5.5M | 105k | 52.26 | |
| Trillium Therapeutics, Inc. Cmn | 2.2 | $5.5M | 250k | 21.82 | |
| Zs Pharma | 2.0 | $5.0M | 95k | 52.39 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.9 | $4.9M | 2.5M | 1.95 | |
| Amarin Corporation (AMRN) | 1.7 | $4.3M | 1.8M | 2.46 | |
| Cara Therapeutics (CARA) | 1.6 | $4.1M | 340k | 12.15 | |
| Eagle Pharmaceuticals (EGRX) | 1.6 | $4.0M | 50k | 80.86 | |
| Adamas Pharmaceuticals | 1.6 | $3.9M | 150k | 26.22 | |
| Macrogenics (MGNX) | 1.4 | $3.4M | 90k | 37.97 | |
| Insys Therapeutics Com New | 1.3 | $3.2M | 89k | 35.92 | |
| Tetraphase Pharmaceuticals | 1.2 | $3.1M | 65k | 47.45 | |
| Inotek Pharmaceuticals Corp conv | 1.2 | $3.0M | 605k | 4.90 | |
| Avinger | 1.1 | $2.7M | 208k | 12.91 | |
| Accelr8 Technology | 1.0 | $2.6M | 101k | 25.81 | |
| XOMA CORP Common equity shares | 1.0 | $2.5M | 650k | 3.88 | |
| Tenax Therapeutics | 0.9 | $2.3M | 635k | 3.69 | |
| Auris Med Hldg | 0.7 | $1.7M | 355k | 4.86 | |
| Tonix Pharmaceuticls | 0.7 | $1.7M | 190k | 8.97 | |
| Zogenix | 0.6 | $1.5M | 913k | 1.68 | |
| Innocoll | 0.6 | $1.5M | 101k | 14.63 | |
| Evoke Pharma | 0.5 | $1.4M | 259k | 5.23 | |
| Celgene Corp Rights | 0.4 | $950k | 457k | 2.08 | |
| Foamix Pharmaceuticals | 0.3 | $871k | 85k | 10.25 | |
| Biolinerx Ltd-spons | 0.2 | $495k | 250k | 1.98 | |
| Agile Therapeutics | 0.2 | $472k | 55k | 8.58 | |
| Neuroderm Ltd F | 0.2 | $399k | 26k | 15.35 | |
| Dermira | 0.1 | $330k | 19k | 17.55 | |
| Tracon Pharmaceuticals | 0.1 | $138k | 12k | 11.34 |
